Delivery Order SPE2DR25D1100-SPE2DR26FCU1E
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by October 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,735.44 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens under a firm fixed-price contract type. The contract is effective as of November 14, 2025, with an ultimate completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, single-source delivery order issued without a set-aside designation. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens on June 6, 2025, with an ultimate completion date of June 30, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 1, 2025, with completion scheduled for December 22, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 11, 2025, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nemluvio (nemtabrutinib) is a targeted therapy used in the treatment of certain hematologic malignancies...
- The Defense Logistics Agency awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on August 26, 2025. This firm fixed-price contract, with a completion date of September 17, 2025, represents a child order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract does not utilize a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nemluvio...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $11,575.20 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract does not utilize a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,735.44 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under a firm fixed-price contract. The award was made on October 30, 2025, with an ultimate completion date of November 21, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,033.08 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of December 26, 2025. This firm fixed-price, non-set-aside contract was awarded on December 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU1EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,099.24 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on December 10, 2025, with completion scheduled for January 2, 2026. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nemluvio (bimekizumab), a biologic medication used in the treatment of inflammatory skin conditions, represents a specialty pharmaceutical product consistent with AmerisourceBergen's role as a major federal medical supplier. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive awards and delivery orders of varying values, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 12/9/25 |